LEXICON PHARMACEUTICALS, INC. Revenue
LEXICON PHARMACEUTICALS, INC. (LXRX) reported Revenue of $692.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Revenue
us-gaap:Revenues · last filed 2026-08-06
- LEXICON PHARMACEUTICALS, INC. revenues for the quarter ending 2026-06-30 was $692.00K, a 97.60% decline year-over-year.
- LEXICON PHARMACEUTICALS, INC. revenues for the quarter ending 2026-03-31 was $21.10M, a 1572.11% increase year-over-year.
- LEXICON PHARMACEUTICALS, INC. revenues for the quarter ending 2025-12-31 was $5.49M, a 79.31% decline year-over-year.
- LEXICON PHARMACEUTICALS, INC. revenues for the quarter ending 2025-09-30 was $14.18M, a 710.40% increase year-over-year.
- LEXICON PHARMACEUTICALS, INC. revenues for fiscal 2025 was $49.80M, a 60.24% increase from fiscal 2024.
- LEXICON PHARMACEUTICALS, INC. revenues for fiscal 2024 was $31.08M, a 2481.48% increase from fiscal 2023.
- LEXICON PHARMACEUTICALS, INC. revenues for fiscal 2023 was $1.20M, a 766.19% increase from fiscal 2022.
- LEXICON PHARMACEUTICALS, INC. revenues for fiscal 2022 was $139.00K, a 53.36% decline from fiscal 2021.
| Period end | Revenues 3 month | Revenues 3 month as first filed | Revenues 6 month | Revenues 6 month as first filed | Revenues 9 month | Revenues 9 month as first filed | Revenues 12 month | Revenues 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $692.00K 10-Q · filed 2026-08-06 | $21.79M 10-Q · filed 2026-08-06 | $27.29M derived: sum of 3 quarters · filed 2026-08-06 | $41.47M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $21.10M 10-Q · filed 2026-05-07 | $26.59M derived: sum of 2 quarters · filed 2026-05-07 | $40.78M derived: sum of 3 quarters · filed 2026-05-07 | $69.64M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $5.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $19.68M derived: sum of 2 quarters · filed 2026-03-05 | $48.54M derived: sum of 3 quarters · filed 2026-08-06 | $49.80M 10-K · filed 2026-03-05 | ||||
| 2025-09-30 | $14.18M 10-Q · filed 2025-11-06 | $43.05M derived: sum of 2 quarters · filed 2026-08-06 | $44.31M 10-Q · filed 2025-11-06 | $70.86M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $28.87M 10-Q · filed 2026-08-06 | $30.13M 10-Q · filed 2026-08-06 | $56.68M derived: sum of 3 quarters · filed 2026-08-06 | $58.43M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $1.26M 10-Q · filed 2026-05-07 | $27.82M derived: sum of 2 quarters · filed 2026-05-07 | $29.57M derived: sum of 3 quarters · filed 2026-05-07 | $31.21M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $26.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $28.30M derived: sum of 2 quarters · filed 2026-03-05 | $29.95M derived: sum of 3 quarters · filed 2026-03-05 | $31.08M 10-K · filed 2026-03-05 | ||||
| 2024-09-30 | $1.75M 10-Q · filed 2025-11-06 | $3.40M derived: sum of 2 quarters · filed 2025-11-06 | $4.53M 10-Q · filed 2025-11-06 | $5.23M derived: sum of 4 quarters · filed 2026-03-05 | ||||
| 2024-06-30 | $1.65M 10-Q · filed 2025-08-06 | $2.78M 10-Q · filed 2025-08-06 | $3.48M derived: sum of 3 quarters · filed 2026-03-05 | $3.64M derived: sum of 4 quarters · filed 2026-03-05 | ||||
| 2024-03-31 | $1.13M 10-Q · filed 2025-05-14 | $1.83M derived: sum of 2 quarters · filed 2026-03-05 | $1.99M derived: sum of 3 quarters · filed 2026-03-05 | $2.31M derived: sum of 4 quarters · filed 2026-03-05 | ||||
| 2023-12-31 | $702.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $864.00K derived: sum of 2 quarters · filed 2026-03-05 | $1.18M derived: sum of 3 quarters · filed 2026-03-05 | $1.20M 10-K · filed 2026-03-05 | ||||
| 2023-09-30 | $162.00K 10-Q · filed 2024-11-13 | $479.00K derived: sum of 2 quarters · filed 2024-11-13 | $502.00K 10-Q · filed 2024-11-13 | $531.00K derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2023-06-30 | $317.00K 10-Q · filed 2024-08-02 | $340.00K 10-Q · filed 2024-08-02 | $369.00K derived: sum of 3 quarters · filed 2025-03-07 | $408.00K derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2023-03-31 | $24.00K 10-Q · filed 2024-05-02 | $52.00K derived: sum of 2 quarters · filed 2025-03-07 | $91.00K derived: sum of 3 quarters · filed 2025-03-07 | $126.00K derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2022-12-31 | $28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $67.00K derived: sum of 2 quarters · filed 2025-03-07 | $102.00K derived: sum of 3 quarters · filed 2025-03-07 | $139.00K 10-K · filed 2025-03-07 | ||||
| 2022-09-30 | $39.00K 10-Q · filed 2023-11-08 | $74.00K derived: sum of 2 quarters · filed 2023-11-08 | $111.00K 10-Q · filed 2023-11-08 | |||||
| 2022-06-30 | $35.00K 10-Q · filed 2023-08-04 | $72.00K 10-Q · filed 2023-08-04 | ||||||
| 2021-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $37.00K derived: sum of 2 quarters · filed 2024-03-25 | $271.00K derived: sum of 3 quarters · filed 2024-03-25 | $298.00K 10-K · filed 2024-03-25 | ||||
| 2021-09-30 | $23.00K 10-Q · filed 2021-11-09 | $257.00K derived: sum of 2 quarters · filed 2021-11-09 | $284.00K 10-Q · filed 2021-11-09 | $483.00K derived: sum of 4 quarters · filed 2023-03-03 | ||||
| 2021-06-30 | $234.00K 10-Q · filed 2021-08-06 | $261.00K 10-Q · filed 2021-08-06 | $460.00K derived: sum of 3 quarters · filed 2023-03-03 | $7.09M derived: sum of 4 quarters · filed 2023-03-03 | ||||
| 2021-03-31 | $27.00K 10-Q · filed 2021-05-06 | $226.00K derived: sum of 2 quarters · filed 2023-03-03 | $6.86M derived: sum of 3 quarters · filed 2023-03-03 | $16.02M derived: sum of 4 quarters · filed 2023-03-03 | ||||
| 2020-12-31 | $199.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | $6.83M derived: sum of 2 quarters · filed 2023-03-03 | $16.00M derived: sum of 3 quarters · filed 2023-03-03 | $24.00M 10-K · filed 2023-03-03 | ||||
| 2020-09-30 | $6.63M 10-Q · filed 2021-11-09 | $15.80M derived: sum of 2 quarters · filed 2021-11-09 | $23.80M 10-Q · filed 2021-11-09 | $32.52M derived: sum of 4 quarters · filed 2021-11-09 | ||||
| 2020-06-30 | $9.16M 10-Q · filed 2021-08-06 | $17.16M 10-Q · filed 2021-08-06 | $25.89M derived: sum of 3 quarters · filed 2021-08-06 | $320.34M derived: sum of 4 quarters · filed 2021-08-06 | ||||
| 2020-03-31 | $8.00M 10-Q · filed 2021-05-06 | $16.73M derived: sum of 2 quarters · filed 2021-05-06 | $311.17M derived: sum of 3 quarters · filed 2021-05-06 | $320.86M derived: sum of 4 quarters · filed 2021-05-06 | ||||
| 2019-12-31 | $8.73M 10-K · filed 2020-03-12 | $303.18M derived: sum of 2 quarters · filed 2020-10-30 | $312.86M derived: sum of 3 quarters · filed 2020-10-30 | $322.07M 10-K · filed 2022-03-10 | ||||
| 2019-09-30 | $294.45M 10-Q · filed 2020-10-30 | $304.13M derived: sum of 2 quarters · filed 2020-10-30 | $313.35M 10-Q · filed 2020-10-30 | $330.42M derived: sum of 4 quarters · filed 2020-10-30 | ||||
| 2019-06-30 | $9.68M 10-Q · filed 2020-07-29 | $18.90M 10-Q · filed 2020-07-29 | $35.97M derived: sum of 3 quarters · filed 2020-07-29 | $42.94M derived: sum of 4 quarters · filed 2020-07-29 | ||||
| 2019-03-31 | $9.22M 10-Q · filed 2020-04-27 | $26.29M derived: sum of 2 quarters · filed 2020-04-27 | $33.25M derived: sum of 3 quarters · filed 2020-04-27 | $47.05M derived: sum of 4 quarters · filed 2020-04-27 | ||||
| 2018-12-31 | $17.07M 10-K · filed 2020-03-12 | $24.04M derived: sum of 2 quarters · filed 2020-03-12 | $37.84M derived: sum of 3 quarters · filed 2020-03-12 | $63.21M 10-K · filed 2021-03-12 | ||||
| 2018-09-30 | $6.97M 10-K · filed 2020-03-12 | $6.86M 10-Q · filed 2018-11-01 | $20.76M derived: sum of 2 quarters · filed 2020-03-12 | $46.14M 10-Q · filed 2019-11-07 | $45.82M 10-Q · filed 2018-11-01 | $80.10M derived: sum of 4 quarters · filed 2020-03-12 | ||
| 2018-06-30 | $13.80M 10-K · filed 2020-03-12 | $13.75M 10-Q · filed 2018-07-30 | $39.17M 10-Q · filed 2019-08-01 | $38.96M 10-Q · filed 2018-07-30 | $73.14M derived: sum of 3 quarters · filed 2020-03-12 | $100.81M derived: sum of 4 quarters · filed 2020-03-12 | ||
| 2018-03-31 | $25.37M 10-K · filed 2020-03-12 | $25.21M 10-Q · filed 2018-05-03 | $59.34M derived: sum of 2 quarters · filed 2020-03-12 | $87.01M derived: sum of 3 quarters · filed 2020-03-12 | $99.10M derived: sum of 4 quarters · filed 2020-03-12 | |||
| 2017-12-31 | $33.97M 10-K · filed 2019-03-15 | $61.64M derived: sum of 2 quarters · filed 2019-03-15 | $73.73M derived: sum of 3 quarters · filed 2019-03-15 | $91.69M 10-K · filed 2020-03-12 | $90.33M 10-K · filed 2018-03-01 | |||
| 2017-09-30 | $27.67M 10-K · filed 2019-03-15 | $26.94M 10-Q · filed 2017-11-08 | $39.76M derived: sum of 2 quarters · filed 2019-03-15 | $57.29M 10-Q · filed 2018-11-01 | $80.76M derived: sum of 4 quarters · filed 2019-03-15 | |||
| 2017-06-30 | $12.09M 10-K · filed 2019-03-15 | $12.05M 10-Q · filed 2017-08-01 | $30.35M 10-Q · filed 2018-07-30 | $53.09M derived: sum of 3 quarters · filed 2019-03-15 | $80.80M derived: sum of 4 quarters · filed 2019-03-15 | |||
| 2017-03-31 | $17.96M 10-K · filed 2019-03-15 | $18.29M 10-Q · filed 2017-05-04 | $41.00M derived: sum of 2 quarters · filed 2019-03-15 | $68.72M derived: sum of 3 quarters · filed 2019-03-15 | $88.81M derived: sum of 4 quarters · filed 2019-03-15 | |||
| 2016-12-31 | $23.04M 10-K · filed 2017-03-06 | $50.75M derived: sum of 2 quarters · filed 2017-11-08 | $70.84M derived: sum of 3 quarters · filed 2017-11-08 | $79.26M 10-K · filed 2019-03-15 | $83.34M 10-K · filed 2017-03-06 | |||
| 2016-09-30 | $27.72M 10-Q · filed 2017-11-08 | $47.81M derived: sum of 2 quarters · filed 2017-11-08 | $60.30M 10-Q · filed 2017-11-08 | $187.58M derived: sum of 4 quarters · filed 2017-11-08 | ||||
| 2016-06-30 | $20.09M 10-Q · filed 2017-08-01 | $32.58M 10-Q · filed 2017-08-01 | $159.86M derived: sum of 3 quarters · filed 2017-08-01 | $160.43M derived: sum of 4 quarters · filed 2017-08-01 | ||||
| 2016-03-31 | $12.49M 10-Q · filed 2017-05-04 | $139.77M derived: sum of 2 quarters · filed 2017-05-04 | $140.34M derived: sum of 3 quarters · filed 2017-05-04 | $140.72M derived: sum of 4 quarters · filed 2017-05-04 | ||||
| 2015-12-31 | $127.28M 10-K · filed 2017-03-06 | $127.85M derived: sum of 2 quarters · filed 2017-03-06 | $128.22M derived: sum of 3 quarters · filed 2017-03-06 | $130.01M 10-K · filed 2018-03-01 | ||||
| 2015-09-30 | $566.00K 10-K · filed 2017-03-06 | $942.00K derived: sum of 2 quarters · filed 2017-03-06 | $2.73M 10-Q · filed 2016-11-07 | $24.22M derived: sum of 4 quarters · filed 2017-03-06 | ||||
| 2015-06-30 | $376.00K 10-K · filed 2017-03-06 | $2.17M 10-Q · filed 2016-08-04 | $23.65M derived: sum of 3 quarters · filed 2017-03-06 | $24.07M derived: sum of 4 quarters · filed 2017-03-06 | ||||
| 2015-03-31 | $1.79M 10-K · filed 2017-03-06 | $23.27M derived: sum of 2 quarters · filed 2017-03-06 | $23.69M derived: sum of 3 quarters · filed 2017-03-06 | $24.37M derived: sum of 4 quarters · filed 2017-03-06 | ||||
| 2014-12-31 | $21.48M 10-K · filed 2016-03-11 | $21.90M derived: sum of 2 quarters · filed 2016-03-11 | $22.58M derived: sum of 3 quarters · filed 2016-03-11 | $22.85M 10-K · filed 2017-03-06 | ||||
| 2014-09-30 | $419.00K 10-K · filed 2016-03-11 | $1.09M derived: sum of 2 quarters · filed 2016-03-11 | $1.37M 10-Q · filed 2015-11-09 | $2.78M derived: sum of 4 quarters · filed 2016-03-11 | ||||
| 2014-06-30 | $676.00K 10-K · filed 2016-03-11 | $953.00K 10-Q · filed 2015-08-07 | $2.36M derived: sum of 3 quarters · filed 2016-03-11 | $2.60M derived: sum of 4 quarters · filed 2016-03-11 | ||||
| 2014-03-31 | $277.00K 10-K · filed 2016-03-11 | $1.69M derived: sum of 2 quarters · filed 2016-03-11 | $1.93M derived: sum of 3 quarters · filed 2016-03-11 | $2.14M derived: sum of 4 quarters · filed 2016-03-11 | ||||
| 2013-12-31 | $1.41M 10-K · filed 2015-03-12 | $1.65M derived: sum of 2 quarters · filed 2015-03-12 | $1.86M derived: sum of 3 quarters · filed 2015-03-12 | $2.22M 10-K · filed 2016-03-11 | ||||
| 2013-09-30 | $238.00K 10-K · filed 2015-03-12 | $452.00K derived: sum of 2 quarters · filed 2015-03-12 | $812.00K 10-Q · filed 2014-11-06 | $1.03M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2013-06-30 | $214.00K 10-K · filed 2015-03-12 | $574.00K 10-Q · filed 2014-08-07 | $792.00K derived: sum of 3 quarters · filed 2015-03-12 | $1.16M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2013-03-31 | $360.00K 10-K · filed 2015-03-12 | $578.00K derived: sum of 2 quarters · filed 2015-03-12 | $950.00K derived: sum of 3 quarters · filed 2015-03-12 | $1.15M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2012-12-31 | $218.00K 10-K · filed 2014-03-07 | $590.00K derived: sum of 2 quarters · filed 2014-03-07 | $789.00K derived: sum of 3 quarters · filed 2014-03-07 | $1.09M 10-K · filed 2015-03-12 | ||||
| 2012-09-30 | $372.00K 10-K · filed 2014-03-07 | $571.00K derived: sum of 2 quarters · filed 2014-03-07 | $871.00K 10-Q · filed 2013-11-12 | $1.21M derived: sum of 4 quarters · filed 2014-03-07 | ||||
| 2012-06-30 | $199.00K 10-K · filed 2014-03-07 | $499.00K 10-Q · filed 2013-08-01 | $842.00K derived: sum of 3 quarters · filed 2014-03-07 | $1.20M derived: sum of 4 quarters · filed 2014-03-07 | ||||
| 2012-03-31 | $300.00K 10-K · filed 2014-03-07 | $643.00K derived: sum of 2 quarters · filed 2014-03-07 | $998.00K derived: sum of 3 quarters · filed 2014-03-07 | $1.55M derived: sum of 4 quarters · filed 2014-03-07 | ||||
| 2011-12-31 | $343.00K 10-K · filed 2013-03-11 | $698.00K derived: sum of 2 quarters · filed 2013-03-11 | $1.25M derived: sum of 3 quarters · filed 2013-03-11 | $1.85M 10-K · filed 2014-03-07 | ||||
| 2011-09-30 | $355.00K 10-K · filed 2013-03-11 | $910.00K derived: sum of 2 quarters · filed 2013-03-11 | $1.51M 10-Q · filed 2012-11-07 | $2.76M derived: sum of 4 quarters · filed 2013-03-11 | ||||
| 2011-06-30 | $555.00K 10-K · filed 2013-03-11 | $1.15M 10-Q · filed 2012-08-02 | $2.40M derived: sum of 3 quarters · filed 2013-03-11 | $3.19M derived: sum of 4 quarters · filed 2013-03-11 | ||||
| 2011-03-31 | $596.00K 10-K · filed 2013-03-11 | $1.85M derived: sum of 2 quarters · filed 2013-03-11 | $2.63M derived: sum of 3 quarters · filed 2013-03-11 | $3.86M derived: sum of 4 quarters · filed 2013-03-11 | ||||
| 2010-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | $2.03M derived: sum of 2 quarters · filed 2013-03-11 | $3.27M derived: sum of 3 quarters · filed 2013-03-11 | $4.91M 10-K · filed 2013-03-11 | ||||
| 2010-09-30 | $781.00K 10-Q · filed 2011-11-01 | $2.01M derived: sum of 2 quarters · filed 2011-11-01 | $3.65M 10-Q · filed 2011-11-01 | |||||
| 2010-06-30 | $1.23M 10-Q · filed 2011-08-09 | $2.87M 10-Q · filed 2011-08-09 | ||||||
| 2009-12-31 | $10.70M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |